Long CA, et al. - Using Medicare data, researchers retrospectively analyzed contemporary patients in the United States who had peripheral vascular intervention with drug-coated balloons to assess patient, physician, and procedural features and cardiovascular and limb events in these patients. This analysis included 83,225 patients who underwent femoropopliteal intervention. The use of drug-coated balloons was done in 29% of all procedures. They found that the rates of all-cause death, all-cause hospitalization, and major amputation at 1 year were lower among patients who underwent femoropopliteal intervention with drug-coated balloons. However, lower rates of repeat revascularization were not seen. Nevertheless, findings are suggestive of the safety of drug-coated balloons among these patients.